""

Gliomas (grade I-III)

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Metastatic Disease: First-Line-Therapy

Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation.
Phase: III
Contact: Sandy Walter / Study Nurse
Clinical Investigator: Prof. Dr. Wolfgang Wick
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04164901
EudraCT-Number: (siehe EU klinisches Studienregister) 2019-002481-13

Metastatic Disease: Follow-Up Care

There are currently no studies available

Other study

There are currently no studies available